v3.26.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Expenses      
Research and development $ 45,377 $ 29,939 $ 24,844
Selling, general and administrative 38,831 10,057 6,824
Total operating expenses 84,208 39,996 31,668
Loss from operations (84,208) (39,996) (31,668)
Other income (expense):      
Interest income 6,640 3,737 74
Interest expense (2) (20) (25)
Other income (expense) (41) 141 (4)
Total other income, net 6,597 3,858 45
Loss before income tax (77,611) (36,138) (31,623)
Income tax expense 0 6 9
Net loss (77,611) (36,144) (31,632)
Other comprehensive income (loss)      
Foreign currency translation adjustments, net of nil tax 124 (286) 18
Total comprehensive loss $ (77,487) $ (36,430) $ (31,614)
Weighted average number of ordinary shares used in per share calculation:      
Basic (in shares) 33,538,160 30,538,378 26,593,673
Diluted (in shares) 33,538,160 30,538,378 26,593,673
Net loss per ordinary share      
Basic (in dollar per share) $ (2.31) $ (1.18) $ (1.19)
Diluted (in dollar per share) $ (2.31) $ (1.18) $ (1.19)